RelCoVax, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.
Phatarphekar A, Vidyadhar Reddy GEC, Gokhale A, Karanam G, Kuchroo P, Shinde K, Masand G, Pagare S, Khadpe N, Pai SS, Vijayan V, Ramnath RL, Pratap Reddy K, Rao P, Harinarayana Rao S, Ramana V.
Phatarphekar A, et al.
Vaccine. 2022 Jul 30;40(32):4522-4530. doi: 10.1016/j.vaccine.2022.06.026. Epub 2022 Jun 13.
Vaccine. 2022.
PMID: 35718590
Free PMC article.
The RelCoVax formulation containing a combination of aluminum hydroxide (alum) and a synthetic CpG oligonucleotide as adjuvants elicited high antibody titers against RBD and N proteins in mice after a prime and boost dose regimen administered 2 weeks apart. The vaccine als …
The RelCoVax formulation containing a combination of aluminum hydroxide (alum) and a synthetic CpG oligonucleotide as adjuvants elicited hig …